Web Event: Rx Drugs and the U.S. Health System: A Conversation about Medicare Prescription Drug Costs

Medicare spent $97 billion on prescription drugs in 2014, accounting for more than a quarter of the nation’s spending on prescription medicines. Those numbers are expected to continue rising in coming years, as spending on the Part D benefit accelerates. Policymakers have put a number of proposals on the table to reduce the growth in Medicare drug spending and costs for beneficiaries, including a controversial proposal that would change the way Medicare pays for Part B drugs administered by doctors.

On Wednesday, September 7, from noon to 1 p.m. ET, the Kaiser Family Foundation hosted a web conversation to discuss trends in Medicare prescription drug spending, as well as proposals to reduce costs and forecasts of what beneficiaries can expect in coming years.

Tricia Neuman, senior vice president and director of the Foundation’s Program on Medicare Policy and its Project on Medicare’s Future, moderated the discussion.

Panelists included:

  • William K. Fleming, PharmD, president, Humana Pharmacy Solutions
  • Richard Frank, Margaret T. Morris Professor of Health Economics, Harvard Medical School
  • Jamey Millar, senior vice president, managed markets and government affairs, GlaxoSmithKline
  • Leigh Purvis, director of health services research, AARP Public Policy Institute
Rx Drugs and the U.S. Health System is a series of web panel discussions hosted by the Kaiser Family Foundation exploring prescription drug costs and spending in the U.S. health system.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.